3627 results for «238»
3627 results
CTO techniques and strategies
11 Oct 2025 – From AICT-AsiaPCR 2025
Explore advanced techniques and strategic approaches in chronic total occlusion (CTO) interventions, including novel methods for severely calcified lesions, bifurcation management, and complex anatomies such as right main CTOs. The session highlights epicardial collateral navigation, device synergy for calcified coronary disease, indigenous perforation techniques, and ultra-low...
Retrievals, foreign bodies and entrapments
11 Oct 2025 – From AICT-AsiaPCR 2025
This session addresses the complexities of retrievals, foreign bodies, and entrapments in interventional cardiology. It presents clinical cases illustrating percutaneous retrieval techniques, management of catheter fractures, iatrogenic dissections, and innovative solutions for challenging scenarios. Emphasis is placed on precision, prevention strategies, and effective problem-solving to mitigate...
The use of adjunct devices in complex PCI
11 Oct 2025 – From AICT-AsiaPCR 2025
This session offers comprehensive education on the use of adjunct devices in complex PCI, focusing on different microcatheter designs and their optimal handling. It includes case-based illustrations demonstrating microcatheter applications, guidance on utilizing pre-shaped angled microcatheters in difficult anatomies, and the pivotal role of extension guide...
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction
03 Apr 2022
Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.
Author
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial
09 Nov 2022
Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.
Author
